Table 3.

Adjusted Odds of Receiving Cancer Therapy for Older Women with Breast Cancer, Alabama, 2000–2002

	BCS (n=2097)	Mastectomy (n=2097)	Radiation after BCS initiated (n=715)	Radiation after BCS completed (n=554)	Adjuvant chemotherapy initiated* (n=1708)	Adjuvant chemotherapy completed (n=280)
Black (vs. white)	1.03 (0.63–1.70)	0.83 (0.53–1.29)	1.13 (0.58–2.18)	1.30 (0.69–2.43)	1.09 (0.64–1.85)	0.66 (0.30–1.45)
Age 75+ years (vs. 66–74)	0.80 (0.65–0.97)	1.32 (1.08–1.61)	0.24 (0.16–0.36)	0.93 (0.63–1.36)	0.22 (0.16–0.29)	0.79 (0.40–1.57)
Stage 2–3 (vs. 1)	0.26 (0.20–0.33)	3.57 (2.81–4.54)	0.83 (0.57–1.20)	0.81 (0.45–1.47)	4.15 (2.94–5.87)	0.99 (0.43–2.31)
Node positive (vs. negative)	—	—	—	—	1.95 (1.44–2.64)	1.32 (0.70–2.49)
Comorbidity index ≥1 (vs. 0)	0.86 (0.69–1.08)	1.24 (0.98–1.56)	0.66 (0.45–0.97)	0.87 (0.54–1.39)	0.65 (0.43–0.99)	0.85 (0.49–1.45)
Standard chemotherapy (vs. no standard chemotherapy)	—	—	2.13 (0.80–5.67)	0.82 (0.40–1.67)	—	—
Doxorubicin-based regimen (vs. other regimens)	—	—	—	—	—	0.65 (0.38–1.11)
Socioeconomic status variables† ≥30% black (vs.<30%)	1.19 (0.87–1.65)	0.88 (0.69–1.13)	0.99 (0.58–1.67)	1.36 (0.73–2.54)	0.79 (0.54– 1.14)	1.23 (0.66–2.31)
≥40% with less high school (vs.<40%)	0.79 (0.63–1.01)	1.26 (1.01–1.57)	1.06 (0.73–1.54)	0.86 (0.45–1.65)	0.96 (0.70–1.33)	1.48 (0.90–2.45)
≥20% below poverty (vs.<20%)	0.80 (0.55–1.15)	1.27 (0.91–1.79)	2.24 (1.28–3.93)	1.12 (0.61–2.04)	1.17 (0.73–1.88)	1.50 (0.84–2.67)
Rural (vs. urban)	1.05 (0.88–1.26)	0.99 (0.83–1.18)	1.02 (0.77–1.34)	0.75 (0.49–1.14)	0.99 (0.69–1.40)	1.56 (0.93–2.63)

Bold denotes statistical significant difference at p<0.05.

^*Among women with tumors greater than 1cm.

^†Socioeconomic status variables were based on Census tract of residence at diagnosis.

BCS, breast conserving surgery.